Asenar
.
///
Borsa
Biz
YZGÜCÜ
BİST
HS Ekranı
Takip
Portföy
BES
Kazan
Haber
Araçlar
Premium
⌂
☀️
Biz
YZGÜCÜ
BİST
HS Ekranı
Takip
Portföy
BES
Kazan
Haber
Araçlar
Premium
Sabitler
Temettüler
Blog
Ekip
Giriş
Çıkış
BIST Hub
›
Pharmaceuticals
› ECZIP
Research
BIST: ECZIP
EİP ECZACIBAŞI İLAÇ PAZARLAMA A.Ş.
OPS (QI)
🔔
Set Alert
⚖
Compare
Share
N/A
Source:
KAP
Market Cap
TRY
N/A
USD
—
EUR
—
Current Snapshot
- 2025 Q4
P/E Ratio
N/A
P/B Ratio
N/A
Gross Margin
25.20%
Op. Margin
N/A
Net Margin
-11.73%
ROE
-853.27%
ROA
-23.75%
Source:
KAP
Debt / Equity
34.92x
Current Ratio
0.85x
Liquidity check
Equity Ratio
2.78%
Asset coverage
EV / EBIT
N/A
Op. profit proxy
EV / Sales
N/A
Enterprise value
Piotroski F
N/A
No data
Altman Z-Score
N/A
No data
Sector Benchmarks
KGK — Tümü · 11,069 companies · FY2023 (latest available)
Sector ROE
22.0%
Net Margin
10.0%
Current Ratio
1.17x
Debt/Equity
0.73x
Latest KAP Filings
Loading filings...
Sector Peers
View all in sector →
SELEC
SELÇUK ECZA DEPOSU TİCARET VE
P/E 31.2
ROE 6.9%
64.6B
ECILC
EİS ECZACIBAŞI İLAÇ SINAİ VE F
P/E 82.6
ROE 1.2%
58.6B
GENIL
GEN İLAÇ VE SAĞLIK ÜRÜNLERİ SA
P/E 22.0
ROE 18.3%
41.7B
DEVA
DEVA HOLDİNG A.Ş.
P/E 17.4
ROE 2.9%
13.2B
TRILC
TURK İLAÇ VE SERUM SANAYİ A.Ş.
P/E 3.0
ROE 16.3%
3.8B
🔒
Unlock Full Analysis
AI-powered analysis, historical charts and full financial data for all 729 BIST companies.
AI Analysis — strengths, risks & outlook
Financial Charts — revenue, margins, returns, valuation
Historical Comparison — full quarterly data table
Get Premium Access
Sign in to your account →
Have a legacy key?
Activate
AI Analysis
Financial Charts
Revenue vs Net Income (1M TRY)
Equity vs Liabilities (1M TRY)
Profit Margins (%)
Returns — ROE vs ROA (%)
Valuation — P/E vs P/B
Advanced Analytics
Profit Cascade (1M TRY)
Revenue & Net Income Growth % (vs prior period)
3-Layer Margin Analysis — Gross, Operating, Net (%)
DuPont ROE Decomposition
Debt Structure — Current Liabilities + Long-term Debt (1M TRY)
Get DCF Valuation
PREMIUM
Historical Comparison
Period
Revenue (1M TRY)
Net Income
Net Margin
ROE
ROA
D/E
P/E
P/B
2025 Q4
6,353,507,529
-745,340,284
-11.73%
-853.27%
-23.75%
34.92x
N/A
N/A